Publications
Discover peer-reviewed publications by therapeutic area.
The information on this page pertains to select publication resources. It is not intended to serve as a comprehensive list of all publications resources.
If you would like to discover more educational content, please use the “Search” feature.
Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.
The provision of this content is not intended to recommend or suggest use of its products in any manner inconsistent with local regulatory approval. For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.
Transthyretin Amyloidosis (ATTR)
Neurofilament light chain as a biomarker for hereditary ATTR amyloidosis
Amyloid
Acute Hepatic Porphyria (AHP)
Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1/2, 48-month open-label extension study
Orphanet Journal of Rare Diseases
Acute Hepatic Porphyria (AHP)
High disease burden and healthcare resource usage in patients with acute porphyria—A population-based analysis
Liver International
Primary Hyperoxaluria Type 1 (PH1)
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial
Frontiers in Pediatrics
Transthyretin Amyloidosis (ATTR)
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
New England Journal of Medicine
Primary Hyperoxaluria Type 1 (PH1)
Reducing diagnostic delays in acute hepatic porphyria using health records data and machine learning
Journal of the American Medical Informatics Association
Transthyretin Amyloidosis (ATTR)
Effectiveness of patisiran after switching from tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy
European Journal of Neurology
Transthyretin Amyloidosis (ATTR)
Six-minute walk test as clinical end point in cardiomyopathy clinical trials, including ATTR-CM: a systematic literature review
Journal of Comparative Effectiveness Research
Acute Hepatic Porphyria (AHP)
A randomized, placebo-controlled study of givosiran in patients with acute hepatic porphyrias (ENVISION): Final (36-month) analysis of the Taiwan Cohort
Journal of the Formosan Medical Association
Primary Hyperoxaluria Type 1 (PH1)
Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical Trial
Kidney International Reports
